Annexon, INC. (ANNX) — 8-K Filings

8-K Filings (15)

• Annexon, Inc. Files 8-K: Material Definitive Agreement — Nov 14, 2025 Risk: medium
  On November 12, 2025, Annexon, Inc. entered into a Material Definitive Agreement. The filing also indicates other events and the submission of financial stateme
• Annexon, Inc. Files 8-K: Corporate Updates — Jun 25, 2025 Risk: low
  On June 23, 2025, Annexon, Inc. filed an 8-K report detailing material modifications to the rights of security holders and financial statements/exhibits. The fi
• Annexon, Inc. Files 8-K on Security Holder Vote Matters — Jun 9, 2025 Risk: low
  On June 5, 2025, Annexon, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing does not disclose specific
• Annexon, Inc. Files 8-K Report — Jan 13, 2025 Risk: low
  On January 13, 2025, Annexon, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or oth
• Annexon, Inc. Files 8-K: Board and Executive Compensation Changes — Jan 10, 2025 Risk: medium
  On January 10, 2025, Annexon, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing includes
• Annexon, Inc. Files 8-K Report — Dec 16, 2024 Risk: low
  On December 16, 2024, Annexon, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or tr
• Annexon, Inc. Files 8-K Report — Oct 22, 2024 Risk: low
  On October 21, 2024, Annexon, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific m
• Annexon, Inc. Files 8-K Report — Aug 5, 2024 Risk: low
  On August 5, 2024, Annexon, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other
• Annexon Appoints New Chief Medical Officer — Jun 25, 2024 Risk: medium
  On June 25, 2024, Annexon, Inc. filed an 8-K report detailing the appointment of Dr. David E. Rick as Chief Medical Officer, effective June 24, 2024. Dr. Rick b
• Annexon, Inc. Reports on Shareholder Vote Matters — Jun 12, 2024 Risk: low
  Annexon, Inc. filed an 8-K on June 12, 2024, reporting on matters submitted to a vote of its security holders on June 5, 2024. The filing details the company's
• Annexon, Inc. Files 8-K for Material Definitive Agreement — Jun 7, 2024 Risk: medium
  On June 5, 2024, Annexon, Inc. entered into a Material Definitive Agreement. The company, incorporated in Delaware with its principal executive offices in Brisb
• Annexon, Inc. Files 8-K Report — Jun 4, 2024 Risk: low
  On June 4, 2024, Annexon, Inc. filed an 8-K report detailing a Regulation FD Disclosure and other events. The filing also includes financial statements and exhi
• Annexon, Inc. Files 8-K Report — May 7, 2024 Risk: low
  On May 7, 2024, Annexon, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific new ma
• Annexon, Inc. Files 8-K Report — Mar 4, 2024 Risk: low
  On March 1, 2024, Annexon, Inc. filed an 8-K report. The filing primarily serves as a notification of an event and includes financial statements and exhibits. N
• Annexon Files Routine 8-K, Confirms Corporate Details — Jan 8, 2024
  Annexon, Inc. filed an 8-K on January 8, 2024, reporting an event that occurred on January 7, 2024. This filing is a routine update to disclose general corporat

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX